CompoAtlas

MEDISTAMINE

Food supplement declared in France, declaration No 2023-6-433, decision dated 7 June 2023

MEDISTAMINE is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
SAS MEDILAB
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
3 gélules
Directions for use
Prendre 1 gélule matin, midi et soir
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes

Declaration 288551, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Plantago major L.FeuilleExtrait sec aqueux200 mg
Ribes nigrum L.BourgeonMacérât hydroglycériné50 mg

Other active ingredients

NamePer day
Méthylsulfonate de méthanenot declared
Membrane d'oeufnot declared
Quercétinenot declared

Additives

Hydroxypropyl Méthyl Cellulose, E460, E470b

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line